Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 895
Article | IMSEAR | ID: sea-221451


Blood transfusion service is a vital part of our health care system. Stringent blood donor screening and medical examination plays a vital role in maintaining the quality and safety of blood components. Voluntary non-remunerated blood donors form the backbone of blood transfusion services. However, regular donation by such voluntary donors may cause significant depletion of iron stores in the body. This has the potential to adversely affect the donor's health, and also to lower the quality of blood being collected subsequently. Even though a pre-donation hemoglobin estimation is routinely done in blood centres, it may fail to recognize subclinical iron store depletion. Testing Ferritin level of all donors is not cost effective and practical in resource limited centres. This study was aimed to identify any significant changes in hematological parameters over repeated blood donations, that may point towards a potential Iron deficiency in an otherwise healthy donor. This was a cross sectional study involving 138 whole blood donors who had attended the blood centre, Department of Transfusion Medicine, Government Medical college, Thiruvananthapuram. The study subjects were categorized into 2 groups based on the number of donations and a Complete blood count (CBC) was done for each group. Data was analyzed using SPSS software, quantitative variables expressed as Mean and Standard Deviation, p value <0.05 was considered statistically significant. Results were analysed by Independent Samples T test. Statistically significant variables were further analysed using Kruskal-Wallis test. Second time blood donors constituted major part of sample size (20/138). Mean Hemoglobin value showed no significant change among the two donor categories. Mean corpuscular volume (MCV) of repeat whole blood donors is significantly lower than infrequent donors independent samples T test, tvalue=3.309. (p-value=0.001). Donors were further subdivided into 5 groups in the order of increasing number of donations and significant difference was observed in MCV and proved by Kruskal-Wallis test(H=19.1344) As per our study, a significant reduction in MCV among repeat donors with a normal hemoglobin value compared to infrequent donors. This might point towards an impending Iron deficiency anemia in near future. A prompt detection of subclinical iron deficiency in voluntary blood donors is the need of the hour since it can cause adverse consequences in donor health and can considerably lower the donor availability as well. Blood centres should take measures like routine Iron stores evaluation of regular repeat donors, educating donors regarding the importance of maintaing a healthy diet, Iron tablet supplementation to prevent donor Iron deficiency anemia (IDA) etc.

Article | IMSEAR | ID: sea-225689


Donating blood is an essential practice that can help save lives. Effective strategies are necessary to attract and keep blood donors to meet the demand for safe blood. To evaluate the experience of voluntary blood donors in Zanzibar, a survey was conducted, and purposive sampling was used to select participants who had donated blood multiple times. The study involved interviewing 15 repeat blood donors, and the data collected was analyzed thematically. Two main themes emerged from the analysis: motivators and barriers. Despite a few negative effects, most participants had positive experiences with repeat blood donation, and only few experienced physical reactions during or after the process. The study concludesthat blood donors in Zanzibar generally have good experience towards repeat blood donation, although community participation, education, and sensitization are needed to recruit and maintain more donors.

Article in Portuguese | LILACS-Express | LILACS, BDENF, SaludCR | ID: biblio-1430298


Introdução: O processo de doação de órgãos e tecidos é definido por ações a fim de transformar um Potencial Doador (PD) em doador efetivo e inicia-se com o diagnóstico de morte encefálica. Objetivo: Analisar o perfil clínico e sociodemográfico dos potenciais doadores de órgãos, como também os fatores que influenciam na doação de órgãos. Métodos: Trata-se de uma pesquisa quantitativa, transversal, retrospectiva e analítica realizada através da coleta de dados de 455 prontuários de pacientes com diagnóstico de Morte Encefálica, de uma Região do Nordeste brasileiro, utilizando formulário estruturado. Posteriormente realizaram-se análises descritivas e nas associações entre as variáveis independentes e dependente, utilizou-se o teste qui-quadrado de Pearson Resultados: As faixas etárias de maior incidência foram entre 21 a 40 anos e 41 a 60 anos, com 33,8% cada, prevalecendo o sexo masculino (64,1%). Em relação à causa da morte, predominou o Trauma Cranioencefálico com 36,5%. Foram entrevistados 83,3% dos familiares e desses, 53,5% autorizaram a doação. Quanto à relação das respostas das entrevistas com os familiares e o sexo dos PD o sexo masculino se destacou com 59,01% das entrevistas positivas, quanto a entrevista e faixa etária, não foram encontradas diferenças significativas. Correlacionando o resultado das entrevistas familiares e a causa da morte, 40,63% destas tinham como causa o trauma cranioencefálico, e desse total, 63,63% tiveram a doação autorizada. Conclusão: A maioria dos doadores efetivos foram jovens e do sexo masculino, com prevalência do trauma craneoencefálico como causa da morte encefálica e da aceitação familiar para a doação.

Introducción: El proceso de donación de órganos y tejidos se define por las acciones encaminadas a transformar a una persona donante potencial (DP) en donante efectiva. Este proceso comienza con el diagnóstico de muerte encefálica. Objetivo: Analizar el perfil clínico y sociodemográfico de potenciales donantes de órganos, así como los factores que influyen en la donación de órganos. Métodos: Se trata de una investigación cuantitativa, transversal, retrospectiva y analítica realizada a partir de la recopilación de datos de 455 prontuarios de pacientes con diagnóstico de muerte encefálica, en una región del Nordeste de Brasil, utilizando un formulario estructurado. Posteriormente, se realizaron análisis descriptivos y, en las asociaciones entre las variables independiente y dependiente, se utilizó la prueba chi-cuadrado de Pearson Resultados: Los grupos de edad con mayor incidencia fueron de 21 a 40 años y de 41 a 60 años, con un 33.8 % cada uno, con predominio del sexo masculino (64.1 %). En cuanto a la causa de muerte, predominó el trauma craneoencefálico con un 36.5 %. Se entrevistó al 83.3 % de familiares y, de este grupo, el 53.5 % autorizó la donación. En cuanto a la relación entre las respuestas de las entrevistas a familiares y el sexo del TP, se destacó el sexo masculino con un 59.01 % de las entrevistas positivas; en cuanto a la entrevista y grupo de edad no se encontraron diferencias significativas. Correlacionando los resultados de las entrevistas familiares y la causa de muerte, el 40.63 % fue por trauma craneoencefálico y, de ese total, el 63.63 % tenía autorizada la donación. Conclusión: Los donantes más efectivos fueron jóvenes y varones, con predominio del traumatismo craneoencefálico como causa de muerte encefálica y aceptación familiar de la donación.

Introduction: The process of organ and tissue donation is defined by actions to transform a Potential Donor (PD) into an effective donor and begins with the diagnosis of brain death. Objective: To analyze the clinical and sociodemographic profile of potential organ donors, as well as the factors that influence organ donation. Methods: This is a quantitative, cross-sectional, retrospective, and analytical research carried out in a region of Northeast Brazil by collecting data from 455 medical records of patients with brain death, who were diagnosed using a structured form. Subsequently, descriptive analyzes were carried out and for the associations between the independent and dependent variables, the Pearson's chi-square test was used. Results: The age groups with the highest incidence were between 21 to 40 years old and 41 to 60 years old, with a 33.8 % each, with a predominance of males (64.1%). Regarding the cause of death, traumatic brain injury was the most common with a 36.5% of the sample. From the 83.3% of the family members that were interviewed, 53.5% of them authorized the donation. Male potential donors constituted the 59.01% of the authorized donations (positive interviews). There was no relationship between the interview results and the age group of the PD. When correlating the results of family interviews and the cause of death, 40.63% of them were caused by traumatic brain injury and, out of this total, 63.63% had the donation authorized. Conclusion: The most effective donors were young and male whose cause of brain death was traumatic brain injury and whose families allowed the donation.

Humans , Transplantation , Tissue and Organ Procurement/methods , Tissue Donors/statistics & numerical data , Brazil
Article | IMSEAR | ID: sea-218084


Background: Researchers have studied the hemodynamic effect of hemorrhage widely but the biochemical alternations after blood loss are less explored. Knowledge about changes in electrolyte values after blood donation may help in assessing the effect on large quantity donations or massive hemorrhage. It may also be beneficial in donor counseling and reassurance. Aims and Objectives: Primary objective of the study was to quantify changes in plasma sodium, potassium, calcium, magnesium, and albumin before and after blood donation. Materials and Methods: Predonation electrolyte and albumin levels were tested in all study subjects as baseline and repeated after 45 min of completed blood donation. Both values were compared with paired t test in SPSS version 17. Results: After 45 min of donating 350 ml whole blood, no significant changes were observed in sodium and potassium levels. Reduction in calcium, magnesium, and albumin was 0.188 mg/dL, 0.0328 mg/dl, and 0.193 g/dl, respectively, which were statistically significant. About 15% of the blood donors were already deficient in magnesium. Conclusions: Calcium, magnesium, and albumin levels were reduced after blood donation but well maintained within the normal level and most of the donors had normal predonation levels. Hence, in large volume or repeated plasma donation and massive blood loss, baseline evaluation, and monitoring of these parameters may be worthwhile.

Article | IMSEAR | ID: sea-220708


PATTERNS OF SEROPREVALENCE FOR TRANSFUSION-TRANSMISSIBLE INFECTIONS AMONG BLOOD DONORS IN A BLOOD CENTRE OF NORTHEAST INDIA Original Research Paper Okram Geet- chandra Singh* Associate Professor, Blood Centre, JNIMS, Imphal *Corresponding Author Introduction: Transfusion– Transmissible Infections (TTIs) are the infections resulting from the introduction of a pathogen into a person through blood transfusion. In an attempt to mitigate the inherent risk of TTIs, the demographic information of blood donors including knowledge on local prevalence of infections and its pattern in the donor population is important for formulating recruitment strategies and planning other precautionary measures. Materials & Methods: This cross-sectional study was conducted in the Blood Centre, Jawaharlal Nehru Institute of Medical Sciences, Imphal between January 2019 and December 2022. All donated blood units were tested for the mandatory TTI markers for HIV 1 & 2, Hepatitis B, Hepatitis C, Syphilis and Malarial parasite. The prevalence and patterns of seropositivity for TTIs were studied based on the donor demographic characteristics such as donation type, gender and age group. The Results: overall seroprevalence among blood donors (n=31,563) was 1.79%. The seroprevalence was lower among voluntary donors (1.08%) than the replacement donors (2.10%). Seropositivities among female and male donors were 0.79% and 1.93% respectively. The lowest TTI seropositivity was seen among female voluntary donors (0.59%) and highest among male replacement donors (2.24%). The seroprevalence for speci?c TTI markers among the blood donors were 0.15% for HIV; 0.57% for HBV; 0.93% for HCV; 0.14% for Syphilis and no donor was found positive for Malaria. The frequency of TTI seropositivity was increased with increase in the age groups of donors in both sexes. There were 9 (0.029%) donors who had co-infection of TTIs. The patterns of TTI markers for co-infections were HCV+HIV=3; HCV+HBV=3; HCV+Syphilis=2 and HIV+ Syphilis=1. Conclusion: The measures to provide safe blood may include collection of blood from the targeted low risk donor population, using more sensitive testing methods, implementing pathogen reduction technologies and other public health measures

Rev. bras. ortop ; 58(1): 23-29, Jan.-Feb. 2023. tab, graf
Article in English | LILACS | ID: biblio-1441344


Abstract Objective The present study aims to highlight the significance of the nucleic acid test (NAT) for musculoskeletal tissue donation and to compare the sensitivity of this test on the different available platforms. Method The present study is a retrospective survey in a human tissue bank database and an integrative literature review encompassing the last 10 years. The PubMed portal and the SCOPUS, CINAHL, and Web of Science databases were queried for articles. Results We found no specific studies on the use and sensitivity of NAT in braindead tissue donors. The information presented in the present study consists of specific contents intended for the Brazilian Blood Transfusion Network (Hemorrede Transfusional Nacional, in Portuguese) and internal retrospective data from a tissue bank located at a city in the state of São Paulo, Brazil. Conclusions The NAT is effective in blood samples from living patients. However, since biochemical reactions in braindead patients can be different, specific research, platforms, or both are crucial to tissue banks.

Resumo Objetivo Evidenciar a importância da realização do teste de ácido nucleico (NAT, na sigla em inglês) para doação de tecidos musculoesqueléticos, assim como comparar a sensibilidade deste exame nas diferentes plataformas existentes no mercado. Método Trata-se de um levantamento retrospectivo no banco de dados de um determinado Banco de Tecidos Humanos e de uma revisão integrativa da literatura, operacionalizada nos últimos 10 anos. As buscas de artigos ocorreram no portal PubMed e nas bases de dados SCOPUS, CINAHL e Web of Science. Resultados Não foram encontrados estudos específicos sobre a utilização e a sensibilidade do exame NAT em pacientes doadores de tecidos com morte encefálica (ME), sendo as informações apresentadas no presente estudo conteúdos específicos destinados à Hemorrede Transfusional Nacional e aos dados retrospectivos internos de um Banco de Tecidos do interior do estado de São Paulo, Brasil. Conclusões O exame NAT se apresenta efetivo em amostras de sangue de pacientes vivos. Porém, reações bioquímicas em pacientes com condições de ME podem se apresentar de formas diferenciadas, tornando-se indispensáveis a realização de pesquisas específicas e/ou a indicação de plataformas aos Bancos de Tecidos.

Humans , Nucleic Acids , Donor Selection
Article | IMSEAR | ID: sea-223537


Background & objectives: The information available regarding delayed adverse donor reactions (D-ADRs) is limited. Proactive follow up of donors for delayed reactions is not done routinely. This study was undertaken to analyze frequency and type of D-ADRs in whole blood donors as also the contributory factors. Methods: In this prospective observational study, all eligible whole blood donors were contacted telephonically twice (24 h and 2 wks after donation) and asked about general health and ADR specific questions. The International Society of Blood Transfusion standard guidelines were used to categorize ADRs. Results: The ADR data of 3514 donors were analyzed in the study. D-ADRs were more common as compared to immediate delayed adverse donor reactions (I-ADRs) (13.7 vs. 2.9%, P<0.001). The most common D-ADRs were bruises (4.98%), fatigue or generalized weakness (4.24%) and sore arms (2.25%). D-ADRs were more common in first time donors as compared to the repeat blood donors (16.1 vs. 12.5%, P=0.002). Females were more prone to D-ADRs (17 vs. 13.6%). Localized D-ADRs were more frequent as compared to systemic D-ADRs (P<0.001). Repeat donors had a lower incidence of systemic D-ADRs (4.11% vs. 7.37%, P<0.001). Interpretation & conclusions: D-ADRs were more common than I-ADRs with a different profile. First time, female and young donors were more prone to D-ADRs. These categories need special care at the time of blood donation. Active follow up of blood donors should be done from time to time to strengthen donor safety

Adv Rheumatol ; 63: 16, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1447153


Abstract Background The prevalence of HLA-B27 gene positivity in healthy Caucasian communities varies between 8 and 14%. However, there is a lack of information in countries with a high rate of miscegenation, such as Brazil. Aim To estimate the frequency of HLA-B27 in the Brazilian general population using a large national registry database. Methods This is a cross-sectional ecological study using the Brazilian Registry of Volunteer Bone Marrow Donors (REDOME) database on HLA-B27 allelic frequency and proportion of positives of healthy donors (18-60 years old). Data were analyzed according to sex, age, race (by self-reported skin color recommended by the Brazilian Institute of Geography and Statistics - IBGE), and geographic region of residence. Results From 1994 to 2022, a total of 5,389,143 healthy bone marrow donors were included. The overall positivity for HLA-B27 was 4.35% (CI 95% 4.32-4.37%), regardless of sex and age (57.2% were women, mean age was 41.7yo). However, there was a difference between races: 4.85% in Whites; 2.92% in Blacks; 3.76% in Pardos (Browns i.e. mixed races); 3.95% in Amarelos (Yellows i.e. Asian Brazilians); and 3.18% in Indigenous. There was also a difference regarding geographic region of residence (North: 3.62%; Northeast: 3.63%; Southeast: 4.29%; Midwest: 4.5% and 5.25% in South). The homozygosity rate for the HLA-B27 was 1.32% of all the positives and only 0.06% in the general population. Conclusions Our findings provide the first Brazilian national prevalence for HLA-B27 in 4.35%. There is a gradient gene positivity from North to South, suggesting that the genetic background related to the miscegenation due to colonization, slavery, and some later waves of immigration together with internal migratory flows, could explain our findings.

Saúde debate ; 47(137): 158-169, abr.-jun. 2023. tab
Article in Portuguese | LILACS-Express | LILACS | ID: biblio-1450464


RESUMO Em diferentes contextos, bem como no processo de doação de sangue, as verdades vão se recriando, e o sujeito vai se constituindo, criando a si mesmo como um sujeito em transformação. A produção de verdades se reflete nas práticas de doação de sangue, por meio da profunda normalização e estigmatização dos processos que as envolvem e que repercutem na disponibilização e qualidade desse produto essencial. O objetivo deste estudo foi compreender a configuração dos regimes de verdade na conformação das práticas de doação de sangue, na perspectiva de candidatos à doação. A metodologia adotada foi de abordagem qualitativa, com coleta de dados realizada por meio de entrevista semiestruturada, com 31 candidatos à doação de repetição, submetidos a análise de discurso. Optou-se, como referência ao termo 'verdade', pela análise de Michel Foucault, enquanto um elemento de constituição do sujeito, produto de múltiplas práticas sociais. Concluiu-se que o processo de doação de sangue é imbuído de um forte caráter normalizador, constituindo-se em relevante elemento de condução dos comportamentos e produção de verdades, impactando as dimensões alcançadas por essas relações de poder nas práticas de doação de sangue, sob o olhar daqueles que se candidatam a fazê-la.

ABSTRACT In different contexts, as well as in the blood donation process, truths are recreated, and the subject is constituted, creating himself as a subject in transformation. The production of truths is reflected in blood donation practices, through the profound normalization and stigmatization of the processes that involve them and that have repercussions on the availability and quality of this essential product. The objective of this study was to understand the configuration of regimes of truth in the conformation of blood donation practices, from the perspective of candidates for donation. The methodology adopted was a qualitative approach, with data collection carried out through semi-structured interviews, with 31 candidates for repeat donation, submitted to speech analysis. It was chosen, as a reference to the term 'truth', the analysis of Michel Foucault, as an element of constitution of the subject, product of multiple social practices. It was concluded that the blood donation process is imbued with a strong normalizing character, constituting a relevant element for conducting behaviors and producing truths, impacting on the dimensions achieved by these power relations in blood donation practices, under the gaze of those applying to do so.

Hematol., Transfus. Cell Ther. (Impr.) ; 45(2): 217-223, Apr.-June 2023. tab, graf
Article in English | LILACS | ID: biblio-1448353


Introduction Collecting high-dose (HD) or double-dose (DD) apheresis platelets units from a single collection offers significant benefit by improving inventory logistics and minimizing the cost per unit produced. Platelet collection yield by apheresis is primarily influenced by donor factors, but the cell separator used also affects the collection yield. Objectives To predict the cutoff in donor factors resulting in HD and DD platelet collections between Trima/Spectra Optia and MCS+ apheresis equipment using Classification and Regression Trees (CART) analysis. Methods High platelet yield collections (target ≥ 4.5 × 1011 platelets) using MCS+, Trima Accel and Spectra Optia were included. Endpoints were ≥ 6 × 1011 platelets for DD and ≥ 4.5 to < 6 × 1011 for HD collections. The CART, a tree building technique, was used to predict the donor factors resulting in high-yield platelet collections in Trima/Spectra Optia and MCS+ equipment by R programming. Results Out of 1,102 donations, the DDs represented 60% and the HDs, 31%. The Trima/Spectra Optia predicted higher success rates when the donor platelet count was set at ≥ 205 × 103/µl and ≥ 237 × 103/µl for HD and DD collections. The MCS+ predicted better success when the donor platelet count was ≥ 286 × 103/µl for HD and ≥ 384 × 103/µl for DD collections. Increased donor weight helped counter the effects of lower donor platelet counts only for HD collections in both the equipment. Conclusions The donor platelet count and weight formed the strongest criteria for predicting high platelet yield donations. Success rates for collecting DD and HD products were higher in the Trima/Spectra Optia, as they require lower donor platelet count and body weight than the MCS+.

Regression Analysis , Platelet Transfusion , Blood Component Removal , Blood Donors , Plateletpheresis
Rev. bras. cir. cardiovasc ; 38(2): 214-218, 2023. tab
Article in English | LILACS-Express | LILACS | ID: biblio-1431503


ABSTRACT Introduction: The aims of this study were to determine the incidence of severe and moderate primary graft dysfunction (PGD) in our center, to identify, retrospectively, donors' and recipients' risk factors for PGD development, and to evaluate the impact of PGD within 30 days after heart transplantation. Methods: Donors' and recipients' medical records of 64 consecutive adult cardiac transplantations performed between January 2016 and June 2017 were reviewed. The International Society for Heart and Lung Transplantation (ISHLT) criteria were used to diagnose moderate and severe PGD. Associations of risk factors for combined moderate/severe PGD were assessed with appropriate statistical analyses. Results: Sixty-four patients underwent heart transplantation in this period. Twelve recipients (18.7%) developed severe or moderate PGD. Development of PGD was associated with previous donor cardiopulmonary resuscitation and a history of prior heart surgery in the recipient (P=0.01 and P=0.02, respectively). The 30-day in hospital mortality was similar in both PGD and non-PGD patients. Conclusion: The use of the ISHLT criteria for PGD is important to identify potential risk factor. The development of PGD did not affect short-term survival in our study. More studies should be done to better understand the pathophysiology of PGD.

Texto & contexto enferm ; 32: e20220148, 2023. tab
Article in English | LILACS-Express | LILACS, BDENF | ID: biblio-1432477


ABSTRACT Objective: to discuss the process of allowing blood donation by the LGBTQIAP+ community by the Federal Supreme Court in contrast to the Legislation of the Regulatory Agency for Blood and Blood Components. Method: this is a reflective study, considering the principles and concepts of Pierre Bourdieu's symbolic capital as a theoretical-methodological framework. Analysis was carried out in documents that dealt with the permission of blood donation by gay and bisexual men, such as bills, FSC decisions and media materials relevant to the proposed theme. Results: we argue that two historical events were decisive for the vote on the act of unconstitutionality by the Federal Supreme Court: the mobilization of lesbian, gay, bisexual and transgender social movements and the coronavirus pandemic. Conclusion: validation of the right to blood donation contributes to the exercise of citizenship of lesbian, gay, bisexual and transgender people.

RESUMEN Objetivo: discutir el proceso de autorización de la donación de sangre por parte de la comunidad LGBTQIAP+ por parte del Supremo Tribunal Federal en contraste con la Legislación de la Agencia Reguladora de Sangre y Hemoderivados. Método: estudio reflexivo, considerando los principios y conceptos del capital simbólico de Pierre Bourdieu como marco teórico-metodológico. El análisis se llevó a cabo en los documentos que trataban sobre el permiso de donación de sangre por parte de hombres homosexuales y bisexuales, como proyectos de ley, decisiones del STF y materiales de prensa relevantes para el tema propuesto. Resultados: argumentamos que dos hechos históricos fueron decisivos para la votación del acto de inconstitucionalidad por parte del Supremo Tribunal Federal: la movilización de los movimientos sociales de lesbianas, gays, bisexuales y transexuales y la pandemia del coronavirus. Conclusión: la validación del derecho a la donación de sangre contribuye al ejercicio de la ciudadanía de las personas lesbianas, gays, bisexuales y transgénero.

RESUMO Objetivo: discutir o processo de permissão da doação de sangue pela comunidade LGBTQIAP+ pelo Supremo Tribunal Federal em contraponto à Legislação da Agência Reguladora de Sangue e Hemoderivados. Método: estudo do tipo reflexivo, considerando os princípios e conceitos do capital simbólico de Pierre Bourdieu como referencial teórico-metodológico. A análise foi realizada nos documentos que tratavam da permissão da doação de sangue por homens gays e bissexuais tais como: projetos de lei, decisões do STF e materiais de mídias pertinentes ao tema proposto. Resultados: argumentamos que dois eventos históricos foram decisivos para a votação do ato de inconstitucionalidade pelo Supremo Tribunal Federal: a mobilização dos movimentos sociais de Lésbicas, Gays, Bissexuais e Transgênero e a Pandemia de Coronavírus. Conclusão: a validação do direito à doação de sangue contribui para o exercício da cidadania das pessoas Lésbicas, Gays, Bissexuais e Transgênero.

J. bras. nefrol ; 44(4): 527-532, Dec. 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1421921


Abstract Introduction: Sensitization to human leukocyte antigen is a barrier to. Few data have been published on desensitization using polyvalent human intravenous immunoglobulin (IVIG) alone. Methods: We retrospectively reviewed the of 45 patients with a positive complement-dependent cytotoxicity crossmatch (CDCXM) or flow cytometry crossmatch (FCXM) against living donors from January 2003 to December 2014. Of these, 12 were excluded. Patients received monthly IVIG infusions (2 g/kg) only until they had a negative T-cell and B-cell FCXM. Results: During the 33 patients, 22 (66.7%) underwent living donor kidney transplantation, 7 (21.2%) received a deceased donor graft, and 4 (12.1%) did not undergo transplantation. The median class I and II panel reactive antibodies for these patients were 80.5% (range 61%-95%) and 83.0% (range 42%-94%), respectively. Patients (81.8%) had a positive T-cell and/or B-cell CDCXM and 4 (18.2%) had a positive T-cell and/or B-cell FCXM. Patients underwent transplantation after a median of 6 (range 3-16). The median donor-specific antibody mean fluorescence intensity sum was 5057 (range 2246-11,691) before and 1389 (range 934-2492) after desensitization (p = 0.0001). Mean patient follow-up time after transplantation was 60.5 (SD, 36.8) months. Nine patients (45.0%). Death-censored graft survival at 1, 3, and 5 years after transplant was 86.4, 86.4, and 79.2%, respectively and patient survival was 95.5, 95.5, and 83.7%, respectively. Conclusions: Desensitization using IVIG alone is an effective strategy, allowing successful transplantation in 87.9% of these highly sensitized patients.

Resumo Introdução: Sensibilização HLA é uma barreira ao transplante em pacientes sensibilizados. Há poucos dados publicados sobre dessensibilização utilizando somente imunoglobulina intravenosa humana polivalente (IgIV). Métodos: Revisamos retrospectivamente prontuários de 45 pacientes com prova cruzada positiva por citotoxicidade dependente do complemento (CDCXM) ou citometria de fluxo (FCXM) contra doadores vivos, de Janeiro/2003-Dezembro/2014. Destes, excluímos 12. 33 pacientes receberam infusões mensais de IgIV (2 g/kg) apenas até apresentarem FCXM células T e B negativa. Resultados: Durante dessensibilização, 22 pacientes (66,7%) realizaram transplante renal com doador vivo, 7 (21,2%) receberam enxerto de doador falecido, 4 (12,1%) não realizaram transplante. A mediana do painel de reatividade de anticorpos classes I e II para estes pacientes foi 80,5% (intervalo 61%-95%) e 83,0% (intervalo 42%-94%), respectivamente. 18 pacientes (81,8%) apresentaram CDCXM célula T e/ou B positiva; 4 (18,2%) apresentaram FCXM célula T e/ou B positiva. Pacientes realizaram transplante após mediana de 6 (intervalo 3-16) infusões. A mediana da somatória da intensidade média de fluorescência do anticorpo específico contra o doador foi 5057 (intervalo 2246-11.691) antes e 1389 (intervalo 934-2492) após dessensibilização (p = 0,0001). O tempo médio de acompanhamento do paciente pós transplante foi 60,5 (DP, 36,8) meses. Nove pacientes (45,0%) não apresentaram rejeição e 6 (27,3%) apresentaram rejeição mediada por anticorpos. Sobrevida do enxerto censurada para óbito em 1, 3, 5 anos após transplante foi 86,4; 86,4; 79,2%, respectivamente, e sobrevida do paciente foi 95,5; 95,5; 83,7%, respectivamente. Conclusões: Dessensibilização utilizando apenas IgIV é uma estratégia eficaz, permitindo transplante bem-sucedido em 87,9% destes pacientes altamente sensibilizados.

Vive (El Alto) ; 5(15): 947-959, dic. 2022.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1424750


La aféresis es el procedimiento más utilizado para la obtención de concentrados plaquetarios de alto rendimiento, calidad y para mejorar las terapias transfusionales en pacientes trombocitopénicos, oncohematológicos,cirugias e incluso, en pacientes con factores clínicos adversos a la refractariedad. Objetivo. Determinar la eficacia de un separador celular en la colecta de plaquetas en un Instituto Nacional de Salud de Lima. Material y métodos. Estudio descriptivo; la muestra fue de 80 concentrados plaquetarios, obtenidos por plaquetoaferesis y utilizando el equipo de separador celular americano. La colecta de plaquetas se realizó en un servicio de Hemoterapia y Banco de Sangre de una institución de salud de Lima, durante los meses de febrero a julio de 2018. La eficacia se realizó evaluando el rendimiento, la eficiencia y el cumplimiento de estándares de calidad aprobados. Uno de los parámetros utilizados fue el recuento de plaquetas y leucocitos residuales, procesados en el analizador hematológico. Resultados. Las evaluaciones fueron: concentración promedio de plaquetas por concentrado plaquetario (rendimiento)= 3,4 x 1011 plaquetas /ml, recuento de leucocitos residuales = 0,07 x 10 6 leucocitos/ml, volumen promedio de sangre procesado = 2480 ml, volumen final promedio = 217,5 ml, eficiencia en la colecta = 56,9 a 63,9 %, el tiempo medio por procedimiento de colecta = 72 minutos. Conclusiones. Los concentrados plaquetarios obtenidos con el procedimiento de plaquetoaferesis cumplen con los estándares de calidad nacional e internacionales, por lo que, se concluye que este procedimiento es eficaz en la colecta de productos de alta calidad que logran la eficacia en la transfusión.

Apheresis is the most widely used procedure to obtain high yield and quality platelet concentrates and to improve transfusion therapies in thrombocytopenic patients, oncohematological patients, surgical patients and even patients with adverse clinical factors to refractoriness. Objective. To determine the efficacy of a cell separator in the collection of platelets in a National Health Institute in Lima. Material and methods. Descriptive study; the sample consisted of 80 platelet concentrates, obtained by plateletpheresis and using American cell separator equipment. The platelet collection was performed in a Hemotherapy and Blood Bank service of a health institution in Lima, during the months of February to July 2018. Effectiveness was performed by evaluating performance, efficiency and compliance with approved quality standards. One of the parameters used was the residual platelet and leukocyte count, processed in the hematological analyzer. Results. The evaluations were: average platelet concentration per platelet concentrate (yield)= 3.4 x 1011 platelets/ml, residual leukocyte count = 0.07 x 10 6 leukocytes/ml, average volume of blood processed = 2480 ml, average final volume = 217.5 ml, collection efficiency = 56.9 to 63.9 %, average time per collection procedure = 72 minutes. Conclusions. The platelet concentrates obtained with the plateletpheresis procedure comply with national and international quality standards, therefore, it is concluded that this procedure is effective in the collection of high quality products that achieve transfusion efficiency.

A aférese é o procedimento mais utilizado para obter concentrados plaquetários de alto rendimento e alta qualidade e para melhorar as terapias transfusionais em pacientes trombocitopênicos, oncohematológicos, cirúrgicos e até mesmo pacientes com fatores clínicos adversos à refratariedade. Objetivo. Para determinar a eficácia de um separador de células na coleta de plaquetas em um Instituto Nacional de Saúde em Lima. Material e métodos. Estudo descritivo; a amostra consistiu de 80 concentrados de plaquetas, obtidos por plaquetaferese e utilizando equipamento separador de células americano. A coleta de plaquetas foi realizada em um serviço de Hemoterapia e Banco de Sangue de uma instituição de saúde em Lima, durante os meses de fevereiro a julho de 2018. A eficácia foi avaliada através da avaliação do desempenho, eficiência e conformidade com os padrões de qualidade aprovados. Um dos parâmetros utilizados foi a contagem residual de plaquetas e leucócitos, processada no analisador hematológico. Resultados. As avaliações foram: concentração média de plaquetas por concentrado de plaquetas (rendimento) = 3,4 x 1011 plaquetas/ml, contagem de leucócitos residuais = 0,07 x 10 6 leucócitos/ml, volume médio de sangue processado = 2480 ml, volume final médio = 217,5 ml, eficiência da coleta = 56,9 a 63,9%, tempo médio por procedimento de coleta = 72 minutos. Conclusões. Os concentrados de plaquetas obtidos com o procedimento de plaquetférese atendem aos padrões de qualidade nacionais e internacionais, portanto, conclui-se que este procedimento é eficaz na coleta de produtos de alta qualidade que alcançam eficiência transfusional.

Blood Platelets , Blood Banks , Blood Component Removal , Plateletpheresis
Enfermeria (Montev.) ; 11(2)dic. 2022.
Article in Spanish | LILACS-Express | LILACS, BDENF | ID: biblio-1404697


Resumen: Objetivo: Este artículo describe los sentimientos relativos a la experiencia de la enfermedad de Chagas en las regiones chilenas de Tarapacá, Atacama y Metropolitana. El estudio se enfocó en los sentimientos y emociones como experiencias subjetivas de mujeres gestantes y donantes de sangre en relación con la problemática de salud de Chagas, aspectos que subyacen en su interacción con el sistema social y sanitario. Método: Se empleó una metodología cualitativa y se utilizaron técnicas como entrevista en profundidad, entrevista semiestructurada y grupos focales. Participaron 176 personas nacionales y migrantes. Resultados: Se observa la relevancia del temor y la culpa, experimentada principalmente por las mujeres. El desconocimiento, desinformación, en el proceso de diagnóstico y tratamiento y los significados atribuidos a la enfermedad son determinantes de la atención. Conclusiones: Para la comprensión de los procesos de salud y las mejoras en el sistema de salud, se deben conocer los sentimientos y emociones en torno a esta problemática. Considerar las subjetividades permiten humanizar las estrategias de abordaje del Chagas.

Resumo: Objetivo: Este artigo descreve os sentimentos relacionados com a experiência da doença de Chagas nas regiões chilenas de Tarapacá, Atacama e Metropolitana. Os sentimentos e emoções como experiências subjetivas de mulheres grávidas e doadores de sangue em relação ao problema de saúde da doença de Chagas, aspectos que fundamentam sua interação com o sistema social e de saúde. Método: Uma metodologia qualitativa foi utilizada e técnicas como entrevistas em profundidade, entrevistas semi-estruturadas e grupos de foco foram utilizadas. Um total de 176 nacionais e migrantes participaram. Resultados: Observamos a relevância do medo e da culpa, principalmente experimentada pelas mulheres. Falta de conhecimento, desinformação, no processo de diagnóstico e tratamento e os significados atribuídos à doença são determinantes para o cuidado. Conclusões: Para a compreensão dos processos de saúde e melhorias no sistema de saúde, os sentimentos e emoções em torno deste problema devem ser conhecidos. Considerando as subjetividades, é possível humanizar as estratégias para lidar com a doença de Chagas.

Abstract: Objective: This article describes the feelings related to the experience of Chagas disease in the Chilean regions of Tarapacá, Atacama and Metropolitan. The study focused on feelings and emotions as subjective experiences of pregnant women and blood donors in relation to the Chagas health problem, aspects that underlie their interaction with the social and health system. Method: A qualitative methodology was employed and techniques such as in-depth interview, semi-structured interview and focus groups were used. A total of 176 nationals and migrants participated. Results: The relevance of fear and guilt, mainly experienced by women, was observed. Lack of knowledge and misinformation in the process of diagnosis and treatment and the meanings attributed to the disease are determinants of care. Conclusions: For the understanding of health processes and improvements in the health system, feelings and emotions around this problematic must be known. Considering subjectivities allows humanizing the strategies for approaching Chagas disease.

Medisur ; 20(6)dic. 2022.
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1440610


En Cuba existe amplia experiencia en el trabajo intersectorial para la solución de problemas de salud en la comunidad y la gestión de las donaciones de sangre no constituye una excepción. Este trabajo tuvo como objetivo documentar sobre el trabajo intersectorial en la gestión de las donaciones de sangre en Cuba y aportar elementos teóricos que contribuyan a su perfeccionamiento. Se realizó una revisión bibliográfica de la literatura sobre la intersectorialidad y los procesos para la gestión de donaciones de sangre en el país; para ello se consultaron trabajos publicados en sitios de Internet, así como textos y otros documentos disponibles en repositorios del portal web de la red Infomed. Se teoriza e ilustra acerca de la intersectorialidad como tecnología gerencial y sobre su uso e importancia aplicados en la promoción, captación y reclutamiento de donantes potenciales así como en la organización de las colectas de sangre. Se concluye que el empleo de la intersectorialidad en la gestión sanitaria de las donaciones voluntarias de sangre fortalece y singulariza el Programa de Donaciones de Sangre cubano con relación al resto del mundo; no obstante, es necesario perfeccionar las alianzas estratégicas entre el sector de la salud y los demás sectores de la sociedad civil organizada que intervienen en las actividades que comprenden este proceso.

In Cuba there is wide experience in intersectoral work to solve health problems in the community and the management of blood donations is no exception. The objective of this work was to document the intersectoral work in the management of blood donations in Cuba and to provide theoretical elements that contribute to its improvement. A bibliographic review of the literature on intersectoriality and the processes for the management of blood donations in the country was carried out; For this, works published on Internet sites were consulted, as well as texts and other documents available in repositories of the Infomed web portal network. Intersectoriality is theorized and illustrated as a managerial technology and its use and importance applied in the promotion, capture and recruitment of potential donors and in the organization of blood collections. It is concluded that the use of intersectoriality in the health management of voluntary blood donations, strengthens and distinguishes the Cuban Blood Donation Program in relation to the rest of the world, however, it is necessary to improve the strategic alliances between the health sector and other sectors of organized civil society involved in the activities that comprise this process.

Article | IMSEAR | ID: sea-223703


Background & objectives: As per national guidelines, prospective blood donors with a history of jaundice of unknown cause are deferred permanently to prevent the transmission of hepatitis B and C. The validity of this guideline was tested by comparing prevalence rates of hepatitis B and C in prospective blood donors deferred due to a history of jaundice, with that of donors who were found fit. Methods: Blood samples of 212 consecutive donors (male, n=203) deferred due to a history of jaundice were studied for hepatitis B and C by rapid test kits as well as by chemiluminescence (n=115) or ELISA (n=97). Consecutive healthy donors (n=549; male, n=518) were also studied by ELISA (n=266) or chemiluminescence (n=283). Results: The cumulative prevalence detected by rapid test kit and ELISA/chemiluminescence tests of hepatitis B (n=10) and C (n=2) among donors deferred due to a history of jaundice (n=212) was 5.7 per cent [95% confidence interval (CI): 2.9, 9.9]. The prevalence of reactive results among healthy donors (n=549) by ELISA/chemiluminescence tests was 3.3 per cent (95% CI: 1.9, 5.2), which included hepatitis B (n=15) and hepatitis C (n=3) cases. Compared to healthy donors, the odds of seropositivity among jaundice-deferred donors was 1.7 (95% CI: 0.8, 3.6), P=0.15. For rapid test-negative deferred donors, the odds of seropositivity by ELISA/chemiluminescence declined to 0.4 (0.1, 1.5), P=0.19. Interpretation & conclusions: The prevalence rates of hepatitis B and C in prospective blood donors deferred due to a history of jaundice of unknown aetiology did not differ significantly from that in healthy donors. The current practice of permanently deferring such donors depletes valuable donor pool. A strategy of rejecting only those donors who are found reactive on pre-donation testing by rapid test needs further validation.

Article | IMSEAR | ID: sea-217738


Background: After collection of blood from a blood donor, it undergoes certain tests for its suitability for transfusion to a recipient. According to the Red Cross, women should have at least a hemoglobin level of 12.5 g/dL and men should have 13 g/dL. Aim and Objectives: The aim of the study was to observe the hemoglobin level of donated blood according to the sex and according to the blood groups – A, AB, B, and O. Materials and Methods: This cross-sectional data audit was conducted with the data of males and females from a blood bank of a tertiary care hospital in India. A total of 4 years of data from 2013 to 2016 were analyzed. The hemoglobin levels were tested by the Shapiro–Wilk normality test. The distribution was not normal. Hence, data were presented as median (first quartile–third quartile) and tested by nonparametric tests – Mann–Whitney test and Kruskal–Wallis test. Results: Total data of 7026 blood donors (6658 [94.76%] males and 368 [5.24%] females) were analyzed in this study. The level is above the cutoff suggested by Red Cross. The overall hemoglobin level was 13.8 (13.2?14.1) g/dL. Male had higher hemoglobin 13.8 (13.2?14.2) g/dL than females 13 (13?13.5) g/dL, P < 0.0001. There was no difference in hemoglobin in A, AB, B, and O blood group in overall, males, and females. Conclusion: There were more male blood donors than female donors. Males have higher hemoglobin levels than females in all types of blood groups in the ABO system. There was no difference in hemoglobin concentration in different blood groups.

Hematol., Transfus. Cell Ther. (Impr.) ; 44(4): 512-518, Oct.-dec. 2022. tab, graf
Article in English | LILACS | ID: biblio-1421522


ABSTRACT Introduction: The safety of a blood transfusion practice is anchored on safe blood from a healthy donor, while further protecting the donor from future harm. This study aimed to evaluate the hematological parameters of blood donors in view of their donor category to aid in assessing the safety threshold in terms of donation frequency. Methods: This study made use of the descriptive cross-sectional design. The blood donors were bled and their samples analyzed using a hematology autoanalyzer. Results: A total of 178 male blood donors were recruited. Most of the donors were aged 18 to 39 years and were mostly students. A greater part of them were repeat donors who had donated blood more than four times. First- and second-time donors constituted the majority of the voluntary donors. While the total red cell count was significantly lower in repeat third-time donors, the hemoglobin and hematocrit of the first-time donors were significantly higher than those of the repeat fourth-time donors. The mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) of the first-time donors were significantly higher than those of the repeat fifth-time donors. The red cell distribution width (RDW) and mean platelet volume (MPV) were significantly lower in the first-time donors from those of the sixth- and seventh-time donors, respectively. Most of the fifth-time donors have subclinical anemia. There was more subclinical anemia in commercial donors than in voluntary donors. Conclusion: Repeat donors more than fifth-time donors are at risk of donation-induced iron deficiency anemia.

Humans , Male , Adolescent , Adult , Middle Aged , Young Adult , Blood Donors , Reference Standards , Blood Safety , Anemia
Hematol., Transfus. Cell Ther. (Impr.) ; 44(4): 472-477, Oct.-dec. 2022. tab
Article in English | LILACS | ID: biblio-1421523


ABSTRACT Introduction: The Zika Virus (ZIKV) is a single-stranded RNA genome virus, belonging to the family Flaviviridae, genus Flavivirus. Outbreaks around the world have demonstrated that the presence of asymptomatic viremic blood donors provides an increase in the risk of transfusion transmission (TT) and nucleic acid test (NAT) screening has been proposed to ensure the blood safety. This study implemented an "in-house" method to detect ZIKV RNA in blood sample donations. Methods: Primary plasma tubes are submitted to nucleic acid extraction on an automated platform. After extraction, the NAT set-up is performed in the robotic pipettor, in which an amplification mixture containing primers and probes for ZIKV and Polio vaccine virus (PV) are added in duplex as an internal control. The real-time polymerase chain reaction is then performed in a thermocycler, using the protocol established by the supplier. Results: From May 2016 to May 2018, 3,369 samples were collected from 3,221 blood donors (confidence coefficient 95%), of which 31 were considered false positive (0.92%), as they did not confirm initial reactivity when repeated in duplicates and 14 (0.42%) had their results invalid due to repeat failure in the internal control, 4 (0.12%), due to insufficient sample volume and 2 (0.05%), due to automatic pipettor failures. No Zika RNA reactive sample was identified. Conclusion: The test showed feasible to be incorporated into the blood screening routine. Our data do not indicate the need to screen for ZIKV RNA in São Paulo during the evaluated period. However, a generic NAT system covering a group of flaviviruses which are circulating in the region, such as DENV and YFV, among others, could be a useful tool.

Humans , Real-Time Polymerase Chain Reaction , Zika Virus , Blood Donors , Blood Transfusion , Flavivirus